Women who received both rounds of the Pfizer-BioNTech vaccine might have a greater level of protection against COVID-19 than men who take the same action, according to a study released Wednesday.

Women 65 years and older were recorded to have higher antibody counts than men in the same age bracket, at 46% and 37%, respectively, according to data from the New England Journal of Medicine.